The year is 2025 but we have been here before. OBR publisher Barry McBride is unhappy about Sunday’s loss, and searches for a ...
Novartis will launch a direct-to-patient (DTP) platform in the US on November 1, 2025, starting with Cosentyx, which will be offered at a 55% dis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results